Adam Dubow - 15 Feb 2024 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
GENERAL COUNSEL
Signature
/s/ Charles N. York II, as Attorney-in-Fact
Issuer symbol
DAWN
Transactions as of
15 Feb 2024
Net transactions value
-$49,434
Form type
4
Filing time
20 Feb 2024, 18:48:04 UTC
Previous filing
09 Jan 2024
Next filing
17 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Options Exercise +2,962 +26% 14,390 15 Feb 2024 Direct F1
transaction DAWN Common Stock Options Exercise +1,750 +12% 16,140 15 Feb 2024 Direct F1
transaction DAWN Common Stock Options Exercise +3,687 +23% 19,827 15 Feb 2024 Direct F1
transaction DAWN Common Stock Sale $49,434 -3,242 -16% $15.25 16,585 16 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DAWN Restricted Stock Unit (RSU) Options Exercise $0 -2,962 -8.3% $0.000000 32,588 15 Feb 2024 Common Stock 2,962 Direct F1, F3
transaction DAWN Restricted Stock Unit (RSU) Options Exercise $0 -1,750 -8.3% $0.000000 19,250 15 Feb 2024 Common Stock 1,750 Direct F1, F4
transaction DAWN Restricted Stock Unit (RSU) Options Exercise $0 -3,687 -6.2% $0.000000 55,313 15 Feb 2024 Common Stock 3,687 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
F2 The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs.
F3 The RSUs vest as to 25% of the total award on November 15, 2023, and 1/12th of the remaining amount vest in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F4 The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.